Trade Mark Journal No.2021/053 31 December 2021
WO0000001631101 (5,40)
Office of origin: United States of America
Date of International Registration:10 November 2021
Date of designation in the UK:
10 November 2021

International priority date claimed: 14 May 2021
(United States of America)
(90712941)
- Class 5
- Pharmaceutical, medicinal, and veterinary preparations and substances, namely, systemic anti-infectives; pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders, allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders.
- Class 40
- Custom manufacture of pharmaceutical preparations and substances for others.
Hikma Pharmaceuticals USA Inc.
Representative: Deborah L. Corpus Pearne & Gordon LLP, 1801 East 9th Street, Suite 1200, Cleveland OH 44114, UNITED STATES OF AMERICA